Thibault Comont

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry

Thibault Comont, Maël Heiblig, Étienne Rivière et al. · British Journal of Haematology · 2021 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

M.L. Piel-Julian, Matthieu Mahévas, Johanne Germain et al. · Journal of Thrombosis and Haemostasis · 2018 · 136 citations · Full text

Medicine, Hematology, Immunology +15

Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort

Guillaume Moulis, Johanne Germain, Thibault Comont et al. · American Journal of Hematology · 2017 · 90 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study

Abdellatif Tazi, Gwenaël Lorillon, Julien Haroche et al. · Orphanet Journal of Rare Diseases · 2017 · 85 citations · Full text

Medicine, Oncology, Pharmacology +16